Author: galiciabiowp

Strong of its two platform technologies based on in silico drug screening technology for small molecules and a new modality for therapeutic peptide, the Japanese biotech company would like to enter into a collaborative research with EU pharmaceutical companies operating in drug research. The agreement could take the shape of a licensing one, financial one or research cooperation one.

A Hungarian research and technology organization (RTO) is looking for partners from pharma and biotechnological industry to join a H2020 MSCA-ITN-ETN European Training Networks proposal. The proposal will set out a training network including experts from both academic and private enterprises, addressing the various aspects of non-natural peptidic compounds. View partnering opportunity...

Read More

AllGenetics' project specialist Rocío Esteban is attending the Programming for Evolutionary Biology(PEB) 2018, an annual event which is being organised this year by the University of Huddersfield. The PEB conference brings together scientists interested in applying bioinformatic tools to answer evolutionary and ecological questions. Rocío will be presenting some results on the application of the reduced-representation library (RRL) method MobiSeq to non-model organisms. MobiSeq has been developed by Dr. Anders...

Read More

Greek company provides an innovative virtual reality platform for surgeon training A Greek company provides an innovative virtual reality platform for surgeon training which transforms health-care outcomes and is appealing to the surgical procedure. This platform is a teaching tool which gives the trainee surgeons the opportunity to get familiar with the instruments and the know-how they need to do the surgery, step by step. The...

Read More

The Galician Bioecosystem Pavillion shows its potential and broadcasts its opportunities through the actions of the Health Knowledge Agency (ACIS), the Galician Innovation Agency (GAIN), the Life Sciences Business Technology Cluster (BIOGA), the Galician Health Cluster (CSG), the University of A Coruña (UDC), the University of Santiago de Compostela (USC) and the University of Vigo (UVigo). Galicia is ranked among the first bioenterprising regions in Spain...

Read More
With this R&D center, the Galicia-based company expects to increase its turnover by 25% over the next two years and step up its growth and internationalisation plan.

 

GalChimia was established in 2001 as a spin-off at the University of Santiago de Compostela in a business venture run by organic chemistry PhDs Carme Pampín and Jacobo Cruces.

 

Its funding comes from its operations and all its share capital is still owned by the entrepreneurial team of Drs Pampín and Cruces, USC Organic Chemistry Department lecturers Gabriel Tojo and Ramón Estévez, and venture capital firm Unirisco Galicia.